Despite FDA’s crackdown, pharma is still spending millions on ads
尽管FDA加大打击力度，制药业仍在为广告投入数百万美元

Last fall, the FDA launched what it called an aggressive crackdown on pharma advertising, sending drugmakers thousands of letters demanding that they remove misleading consumer ads.
去年秋天，FDA发起了其称之为对制药广告的强力整治行动，向药企发出数千封信，要求其撤下具有误导性的消费者广告。